Would you consider long term avatrombopag use in patients with cirrhosis requiring higher platelet counts for medical therapy?
For example, someone needing a higher platelet count for dual antiplatelet agent use after coronary stent placement.
Community PollStarted
Would you use chronic TPO-RA for cirrhosis requiring higher platelet for medical therapy?
41 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Hematology · University of Rochester School of Medicine and Dentistry
Answered on · Updated on
In general, no, I would not use long-term avatrombopag in patients with cirrhosis requiring higher platelet counts for medical therapy due to the perceived thrombotic risk and hemostatic abnormalities of patients with liver disease.
One thing to note in assessing the risk of long-term TPO mimetic the...
Join for free or sign in to see the full answer